Related Experiment Video
Updated: Mar 17, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Mesenchymal stem cell-derived exosomes: A novel potential therapeutic avenue for cardiac regeneration
S Safari1, F Malekvandfard2, S Babashah3
1Iran University of Medical Sciences Department of Anesthesiology, Rasoul Akram Medical Center Tehran Iran.
Insights
Mesenchymal stem cells (MSCs) show promise for treating cardiac damage. Evidence suggests MSCs exert therapeutic effects via paracrine factors, particularly MSC-derived exosomes (MSC-EXs), for heart repair.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Coronary artery diseases (CADs) remain a leading cause of mortality globally.
- While cardiac stem cells exist, their regenerative capacity is insufficient for repairing heart damage, leading to scar formation.
- Current stem cell therapies aim to replace damaged cardiac cells, but their efficacy is debated.
Purpose of the Study:
- To review evidence supporting the paracrine hypothesis of mesenchymal stem cells (MSCs) in cardiac repair.
- To focus on the therapeutic potential of MSC-derived exosomes (MSC-EXs) for treating CADs and ischemic myocardial dysfunction.
Main Methods:
- Review of current scientific literature on MSCs and cardiac regeneration.
- Analysis of studies investigating the paracrine mechanisms of MSCs.
- Focus on the role and therapeutic application of MSC-derived exosomes.
Main Results:
- The regenerative capacity of MSCs may not solely rely on direct cell differentiation.
- Paracrine factors secreted by MSCs play a significant role in their therapeutic effects.
- MSC-derived exosomes (MSC-EXs) are emerging as key mediators of these paracrine effects.
Conclusions:
- The paracrine action of MSCs, especially via MSC-EXs, offers a promising therapeutic strategy for CADs.
- MSC-EXs represent a potential cell-free therapeutic modality for ischemic myocardial dysfunction.
- Further research into MSC-EXs could advance the treatment of heart diseases.
Abstract:
Coronary artery diseases (CADs) represent a significant cause of death worldwide. During recent decades the rate of cardiovascular mortality has been declined as a result of modern medicine and surgery. However, despite the fact that cardiac cells, including cardiomyocytes (CMCs), vascular smooth muscle cells (VSMC) and vascular endothelial cells (VEC), can be regenerated by cardiac adult stem cell, the regenerative capacity of these cells are limited and inadequate to functionally regenerate heart damaged tissue. Thus, growth reserve of the heart fails to restore the structural integrity of the myocardium after infarction and healing is associated with scar formation. An explanation for this is that cardiac reside stem cells are present throughout the infarction site but die rapidly by apoptosis. Furthermore, microenvironment surrounding the damage site is not promising for the cells survival and renewal. Hence, recent advances in the stem cell therapy have emerged as an attractive approach to replace the lost cells. In this context, mesenchymal stem cells (MSCs) has considered as one of the most promising candidates for regeneration of cardiac cells, lost upon injury. The regenerative capacity of MSCs has primarily been centered on the hypothesis that these cells would engraft, differentiate and replace damaged cardiac cells. However, experimental and clinical observations so far have failed to establish if this differentiated is considerably relevant to MSCs cardiac regenerative properties. Recent reports have suggested that these therapeutic properties, at least in part, are mediated by paracrine factors released from MSCs. This review provides a concise summary of current evidences supporting the paracrine hypothesis of MSCs. In particular, the scope of this review focuses on the role of MSC-derived exosome (MSC-EXs) as a therapeutic modality for the treatment of CADs, particularly ischemic myocardial dysfunctions.
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

